Independent perspectives on apps & Apple.

RSS   Partner with us ↗

Apps. Tech. Deals.

Brain Fit: separate a puzzle score from a health claim

A cautious guide to interpreting brain-game marketing, with the original 2009 app identity still unverified.

Original games illustration for Brain Fit: separate a puzzle score from a health claim

What is known about this old link

The original application behind the 2009 Brain Fit address has not been conclusively identified. This page therefore does not assign it to a modern company or reconstruct its features. It offers a new guide to evaluating the kind of claim suggested by the title.

A game result answers a limited question

Improving at a familiar puzzle shows that a person performed differently on that puzzle. By itself, it does not establish improved everyday memory, school performance, or protection from a health condition. Those are different claims and need evidence designed to assess them.

Keep this distinction in mind when a colorful progress chart appears. A rising score may reflect learning the rules, recognizing repeated patterns, or becoming more comfortable with the controls.

Look for evidence behind broad promises

The US Federal Trade Commission’s 2016 Lumosity announcement describes a settlement over allegedly unsupported brain-training claims. That case concerned Lumosity, not an identified Brain Fit app. It is relevant as an example of why broad benefits should not be accepted merely because a product describes itself as brain training.

Choose entertainment on its own merits

If you enjoy puzzles, evaluate the puzzle experience: clear rules, comfortable difficulty, readable controls, and commercial terms you understand. There is no need to invent a medical benefit to justify enjoying a game.

For a health concern, seek appropriate professional advice rather than interpreting an app’s score as an assessment. This page provides no diagnosis or treatment recommendation. The historical Brain Fit identity remains open to better archival evidence, and no similarly named current product is endorsed as the original.